Deploys quantitative strategies across global equity and macro markets using proprietary data science, statistical arbitrage and high-frequency signal generation. Vectors Research Management targets absolute returns with multi-strategy hedge funds and separately managed accounts, allocating capital to long/short equities, event-driven trades and systematic macro overlays. Clients include institutional allocators and family offices seeking diversified, model-driven exposure and risk-managed alpha extraction.
Deploys quantitative strategies across global equity and macro markets using proprietary data science, statistical arbitrage and high-frequency signal generation. Vectors Research Management targets absolute returns with multi-strategy hedge funds and separately managed accounts, allocating capital to long/short equities, event-driven trades and systematic macro overlays. Clients include institutional allocators and family offices seeking diversified, model-driven exposure and risk-managed alpha extraction.
Operates a quantitatively driven, multi-strategy hedge fund model emphasizing absolute return through statistical arbitrage, high‑frequency signals and systematic macro overlays. Capital deployment blends long/short equity, event‑driven and macro exposures with dynamic risk parity and volatility-targeting to preserve capital across cycles. Underwriting prioritizes signal validation, capacity-aware trades and low correlation sources; portfolio construction favors diversified, model-led bets over single-name concentration, positioning the firm as a turnkey, institutional-grade alpha generator.
Operates a quantitatively driven, multi-strategy hedge fund model emphasizing absolute return through statistical arbitrage, high‑frequency signals and systematic macro overlays. Capital deployment blends long/short equity, event‑driven and macro exposures with dynamic risk parity and volatility-targeting to preserve capital across cycles. Underwriting prioritizes signal validation, capacity-aware trades and low correlation sources; portfolio construction favors diversified, model-led bets over single-name concentration, positioning the firm as a turnkey, institutional-grade alpha generator.
| Trades 5951 | Longs Won 3116/5951 52% | Profit Factor 4.02 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $204,885.63 |
| Average Win $72,253.4 | Best Trade (Oct 16) $6.6M | Sharpe Ratio -55.37 |
| Average Loss -$19,732.04 | Worst Trade (Mar 30) -$3.74M | Z-Score -18.88 (100%) |
| Commissions $0 | Avg. Trade Length 1y 11m 3w 5d | Expectancy $28,422.87 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 19,231 | 17,308 | 15,385 | 13,462 | 11,538 | 9,615 | 7,692 | 5,769 | 3,846 | 1,923 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 42,596 | $5.16M | $14.7M | - | $9.53M | 184.63% | +0.901% |
ABBV AbbVie Inc. | 1,505 | $149,877.88 | $429,602.25 | - | $279,724.37 | 186.63% | +0.723% |
ABT Abbott Laboratories | 14,565 | $1.74M | $1.53M | - | -$208,420.79 | -11.99% | +0.334% |
ADM Archer-Daniels-Midland Co | 3,223 | $234,280 | $269,152.73 | - | $34,872.73 | 14.89% | +0.699% |
AEP American Electric Power Company, Inc. | 21,279 | $2M | $2.69M | - | $684,755.56 | 34.19% | +1.616% |
AIQ Global X Artificial Intelligence & Technology ETF | 8,970 | $418,629.93 | $567,531.9 | - | $148,901.97 | 35.57% | -1.279% |
AMAT Applied Materials, Inc. | 850 | $614,555 | $359,167.5 | - | -$255,387.5 | -41.56% | -1.735% |
AMD Advanced Micro Devices, Inc. | 11,619 | $2.12M | $6.34M | - | $4.22M | 198.86% | -2.976% |
AMP Ameriprise Financial, Inc. | 2,480 | $321,219.5 | $1.25M | - | $930,721.7 | 289.75% | +0.445% |
AMZN Amazon.com Inc | 2,094 | $440,778.7 | $530,671.95 | - | $89,893.25 | 20.39% | -0.524% |
AVGO Broadcom Inc. | 9,024 | $2.78M | $3.05M | - | $275,056.69 | 9.9% | -1.777% |
AXP American Express Company | 5,340 | $660,166.6 | $1.7M | - | $1.04M | 157.29% | +1.34% |
BAC Bank of America Corporation | 55,581 | $2.3M | $2.9M | - | $601,512.43 | 26.12% | +1.064% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 2,266 | $207,656 | $207,452.3 | - | -$203.7 | -0.1% | +0.011% |
| BKT BKT | 35,076 | $432,794.04 | $432,794.04 | - | - | - | 0.0 |
BMY Bristol-Myers Squibb Company | 13,000 | $680,652.66 | $790,660 | - | $110,007.34 | 16.16% | +0.413% |
BND Vanguard Total Bond Market Index Fund | 103,135 | $7.43M | $7.31M | - | -$115,914.07 | -1.56% | +0.139% |
BNY BlackRock New York Municipal Income Trust | 14,278 | $1.6M | $2.05M | - | $452,381.07 | 28.27% | +1.175% |
BSV Vanguard Short-Term Bond ETF | 8,911 | $697,841.88 | $683,072.7 | - | -$14,769.18 | -2.12% | +0.124% |
BSX Boston Scientific Corporation | 13,103 | $926,868.71 | $580,987.02 | - | -$345,881.69 | -37.32% | +0.453% |